{"id":44091,"date":"2026-06-09T10:54:58","date_gmt":"2026-06-09T08:54:58","guid":{"rendered":"https:\/\/celonpharma.com\/?p=44091"},"modified":"2026-06-09T10:54:59","modified_gmt":"2026-06-09T08:54:59","slug":"celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries","status":"publish","type":"post","link":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/","title":{"rendered":"Celon Pharma S.A. Partners for the Commercialization of Reduzek (generics semaglutide) \u00a0in the Gulf Cooperation Council (GCC) Countries"},"content":{"rendered":"\n

<\/p>\n\n\n\n

Celon Pharma S.A. has entered into a License and Supply Agreement with Pharmalink Drug Store L.L.C. for the commercialization of Celon Pharma\u2019s generic semaglutide products in selected markets of the Gulf Cooperation Council (GCC) countries. The partnership represents another step in the Company\u2019s strategy to build an international commercial presence for its GLP-1 analogue portfolio.<\/p>\n\n\n\n

Under the agreement, Pharmalink is granted exclusive rights, subject to the fulfillment of contractual obligations and applicable legal requirements, to register, market, distribute, promote, and sell Celon Pharma\u2019s generic semaglutide products in Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, Bahrain, and Oman.<\/p>\n\n\n\n

Celon Pharma will remain responsible for product supply as well as support related to regulatory documentation and manufacturing processes.<\/p>\n\n\n\n

The GCC region is strategically important for the development of high-quality pharmaceutical partnerships, particularly in therapeutic areas related to diabetes, obesity, and the long-term management of metabolic disorders.<\/p>\n\n\n\n

\n

Mr Abdul Rauf Jabour CEO of Pharmalink \u00a0Drug Store L.L.C. commented: <\/strong>We believe that Pharmalink\u2019s local market knowledge, well-established regulatory capabilities, logistics infrastructure, and commercial presence will effectively support successful launch and commercialization of Celon Pharma\u2019s Reduzek (generic semaglutide)\u201d.<\/p>\n<\/blockquote>\n\n\n\n

\n

The agreement with Pharmalink is the first of many steps in our business development strategy focused on creating value through carefully selected regional partnerships. The GCC countries represent an important market environment for our growth, and Pharmalink possesses the local capabilities required to support product registration and successful launch in GCC region –\u00a0 said Maciej Wieczorek, Chief Executive Officer of Celon Pharma S.A.<\/strong>.<\/p>\n<\/blockquote>\n\n\n\n

\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"

Celon Pharma S.A. has entered into a License and Supply Agreement with Pharmalink Drug Store L.L.C. for the commercialization of Celon Pharma\u2019s generic semaglutide products in selected markets of the Gulf Cooperation Council (GCC) countries. The partnership represents another step in the Company\u2019s strategy to build an international commercial presence for its GLP-1 analogue portfolio.Read more »<\/a><\/p>\n","protected":false},"author":20,"featured_media":28792,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[30],"tags":[],"class_list":["post-44091","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en"],"acf":[],"yoast_head":"\nCelon Pharma S.A. Partners for the Commercialization of Reduzek (generics semaglutide) \u00a0in the Gulf Cooperation Council (GCC) Countries - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celon Pharma S.A. Partners for the Commercialization of Reduzek (generics semaglutide) \u00a0in the Gulf Cooperation Council (GCC) Countries - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"Celon Pharma S.A. has entered into a License and Supply Agreement with Pharmalink Drug Store L.L.C. for the commercialization of Celon Pharma\u2019s generic semaglutide products in selected markets of the Gulf Cooperation Council (GCC) countries. The partnership represents another step in the Company\u2019s strategy to build an international commercial presence for its GLP-1 analogue portfolio.Read more »\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-09T08:54:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-09T08:54:59+00:00\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\\\/\"},\"author\":{\"name\":\"Ma\u0142gorzata Siewierska\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/086a66251c93953fa818392fd883740c\"},\"headline\":\"Celon Pharma S.A. Partners for the Commercialization of Reduzek (generics semaglutide) \u00a0in the Gulf Cooperation Council (GCC) Countries\",\"datePublished\":\"2026-06-09T08:54:58+00:00\",\"dateModified\":\"2026-06-09T08:54:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\\\/\"},\"wordCount\":277,\"image\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/badania-i-rozwoj-publikacje.svg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\\\/\",\"name\":\"Celon Pharma S.A. Partners for the Commercialization of Reduzek (generics semaglutide) \u00a0in the Gulf Cooperation Council (GCC) Countries - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/badania-i-rozwoj-publikacje.svg\",\"datePublished\":\"2026-06-09T08:54:58+00:00\",\"dateModified\":\"2026-06-09T08:54:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/086a66251c93953fa818392fd883740c\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\\\/#primaryimage\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/badania-i-rozwoj-publikacje.svg\",\"contentUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/badania-i-rozwoj-publikacje.svg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celon Pharma S.A. Partners for the Commercialization of Reduzek (generics semaglutide) \u00a0in the Gulf Cooperation Council (GCC) Countries\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/086a66251c93953fa818392fd883740c\",\"name\":\"Ma\u0142gorzata Siewierska\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celon Pharma S.A. Partners for the Commercialization of Reduzek (generics semaglutide) \u00a0in the Gulf Cooperation Council (GCC) Countries - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/","og_locale":"en_US","og_type":"article","og_title":"Celon Pharma S.A. Partners for the Commercialization of Reduzek (generics semaglutide) \u00a0in the Gulf Cooperation Council (GCC) Countries - Celon Pharma","og_description":"Celon Pharma S.A. has entered into a License and Supply Agreement with Pharmalink Drug Store L.L.C. for the commercialization of Celon Pharma\u2019s generic semaglutide products in selected markets of the Gulf Cooperation Council (GCC) countries. The partnership represents another step in the Company\u2019s strategy to build an international commercial presence for its GLP-1 analogue portfolio.Read more »","og_url":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/","og_site_name":"Celon Pharma","article_published_time":"2026-06-09T08:54:58+00:00","article_modified_time":"2026-06-09T08:54:59+00:00","author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/#article","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/"},"author":{"name":"Ma\u0142gorzata Siewierska","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/086a66251c93953fa818392fd883740c"},"headline":"Celon Pharma S.A. Partners for the Commercialization of Reduzek (generics semaglutide) \u00a0in the Gulf Cooperation Council (GCC) Countries","datePublished":"2026-06-09T08:54:58+00:00","dateModified":"2026-06-09T08:54:59+00:00","mainEntityOfPage":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/"},"wordCount":277,"image":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/#primaryimage"},"thumbnailUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2023\/04\/badania-i-rozwoj-publikacje.svg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/","url":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/","name":"Celon Pharma S.A. Partners for the Commercialization of Reduzek (generics semaglutide) \u00a0in the Gulf Cooperation Council (GCC) Countries - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/#primaryimage"},"image":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/#primaryimage"},"thumbnailUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2023\/04\/badania-i-rozwoj-publikacje.svg","datePublished":"2026-06-09T08:54:58+00:00","dateModified":"2026-06-09T08:54:59+00:00","author":{"@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/086a66251c93953fa818392fd883740c"},"breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/#primaryimage","url":"https:\/\/celonpharma.com\/wp-content\/uploads\/2023\/04\/badania-i-rozwoj-publikacje.svg","contentUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2023\/04\/badania-i-rozwoj-publikacje.svg"},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-partners-for-the-commercialization-of-reduzek-generics-semaglutide-in-the-gulf-cooperation-council-gcc-countries\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Celon Pharma S.A. Partners for the Commercialization of Reduzek (generics semaglutide) \u00a0in the Gulf Cooperation Council (GCC) Countries"}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/086a66251c93953fa818392fd883740c","name":"Ma\u0142gorzata Siewierska"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/44091","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=44091"}],"version-history":[{"count":1,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/44091\/revisions"}],"predecessor-version":[{"id":44092,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/44091\/revisions\/44092"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media\/28792"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=44091"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/categories?post=44091"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/tags?post=44091"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}